ImmPACT-Bio
Israel
1-10 employees
Established in 2017
Company description
See translation
ImmPACT-Bio is developing a strategy to differentiate cancerous from noncancerous tissues in order to improve the safety of chimeric antigen receptor T-cell (CAR-T) therapy. The company's product is designed to assure tumor specificity by inducing cytoto...
{{industry.name}}
{{pas.productName}}
HS code: {{pas.hsCode | limitTo: 23}}
HS code: {{pas.hsCode | limitTo: 23}}
Show more
Commercial information
Affiliations:
Start-Up Nation Central
This information is provided by Start-Up Nation Finder
Click here to see more
People in this company (1)
Contact this company through Start-Up Nation Central
To get in touch with the ConnectAmericas support team, please send an e-mail with your request to soporte@connectamericas.com and we will get back to you briefly.
Follow Us